Jin Medical Gets Nasdaq Listing Deficiency Notice
Ticker: ZJYL · Form: 6-K · Filed: May 6, 2025 · CIK: 1837821
| Field | Detail |
|---|---|
| Company | Jin Medical International Ltd. (ZJYL) |
| Form Type | 6-K |
| Filed Date | May 6, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: listing-standards, delisting-risk, sec-filing
TL;DR
Nasdaq sent Jin Medical a notice they're not meeting listing rules; they have until Oct 29 to fix it or get booted.
AI Summary
On May 2, 2025, Jin Medical International Ltd. received a deficiency letter from Nasdaq regarding its continued listing standards. The company is required to submit a plan to regain compliance by July 1, 2025, and must demonstrate compliance within 180 days from the date of the notice, which is by October 29, 2025.
Why It Matters
This notice indicates potential delisting from Nasdaq, which could significantly impact the company's stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — Failure to regain compliance with Nasdaq's listing standards could lead to delisting, severely impacting the company's market access and valuation.
Key Players & Entities
- Jin Medical International Ltd. (company) — The company that received the notice.
- Nasdaq (company) — The stock exchange that issued the deficiency letter.
- May 2, 2025 (date) — Date the deficiency letter was received.
- July 1, 2025 (date) — Deadline for submitting a compliance plan.
- October 29, 2025 (date) — Deadline to demonstrate compliance with listing standards.
FAQ
What specific continued listing standards did Jin Medical International Ltd. fail to meet?
The filing does not specify the exact continued listing standards that Jin Medical International Ltd. failed to meet, only that a deficiency letter was received.
What is the deadline for Jin Medical International Ltd. to submit a plan to regain compliance with Nasdaq's listing standards?
Jin Medical International Ltd. must submit a plan to regain compliance by July 1, 2025.
What is the maximum period Jin Medical International Ltd. has to regain compliance with Nasdaq's listing standards?
The company must demonstrate compliance within 180 days from the date of the notice, which is by October 29, 2025.
What is the name of the Nasdaq department that issued the deficiency letter?
The deficiency letter was issued by the Nasdaq Listing Qualifications Department.
What form was filed with the SEC regarding this notice?
A Form 6-K was filed with the SEC to report this information.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 6, 2025 regarding Jin Medical International Ltd. (ZJYL).